1. Home
  2. CCLD vs TLSA Comparison

CCLD vs TLSA Comparison

Compare CCLD & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCLD
  • TLSA
  • Stock Information
  • Founded
  • CCLD 1999
  • TLSA 2013
  • Country
  • CCLD United States
  • TLSA United Kingdom
  • Employees
  • CCLD N/A
  • TLSA N/A
  • Industry
  • CCLD Computer Software: Prepackaged Software
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCLD Technology
  • TLSA Health Care
  • Exchange
  • CCLD Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • CCLD 157.0M
  • TLSA 187.0M
  • IPO Year
  • CCLD 2014
  • TLSA 2000
  • Fundamental
  • Price
  • CCLD $3.35
  • TLSA $1.66
  • Analyst Decision
  • CCLD Buy
  • TLSA
  • Analyst Count
  • CCLD 2
  • TLSA 0
  • Target Price
  • CCLD $3.00
  • TLSA N/A
  • AVG Volume (30 Days)
  • CCLD 756.1K
  • TLSA 325.5K
  • Earning Date
  • CCLD 11-11-2025
  • TLSA 05-06-2025
  • Dividend Yield
  • CCLD N/A
  • TLSA N/A
  • EPS Growth
  • CCLD N/A
  • TLSA N/A
  • EPS
  • CCLD 0.00
  • TLSA N/A
  • Revenue
  • CCLD $111,794,000.00
  • TLSA N/A
  • Revenue This Year
  • CCLD $2.20
  • TLSA N/A
  • Revenue Next Year
  • CCLD $7.53
  • TLSA N/A
  • P/E Ratio
  • CCLD $8,738.26
  • TLSA N/A
  • Revenue Growth
  • CCLD 0.04
  • TLSA N/A
  • 52 Week Low
  • CCLD $1.14
  • TLSA $0.63
  • 52 Week High
  • CCLD $4.84
  • TLSA $2.60
  • Technical
  • Relative Strength Index (RSI)
  • CCLD 52.44
  • TLSA 43.10
  • Support Level
  • CCLD $3.35
  • TLSA $1.63
  • Resistance Level
  • CCLD $3.98
  • TLSA $1.88
  • Average True Range (ATR)
  • CCLD 0.23
  • TLSA 0.15
  • MACD
  • CCLD -0.05
  • TLSA -0.01
  • Stochastic Oscillator
  • CCLD 2.94
  • TLSA 38.46

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: